Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma
C. Manegold(Heidelberg University), James T. Symanowski(Eli Lilly (United States)), U. Gatzemeier(LungenClinic Grosshansdorf), Martin Reck(LungenClinic Grosshansdorf), Joachim von Pawel(Asklepios Fachkliniken München-Gauting), C. Kortsik(St. Bernward Krankenhaus), K. Nackaerts(Universitair Ziekenhuis Leuven), P. Lianes(Hospital de Mataró), Nicholas J. Vogelzang
Cited by 163
Abstract
Related Papers
No related papers found
Powered by citation graph analysis